Company Description
Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.
It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems.
It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs.
The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018.
Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.
| Country | United States |
| Founded | 2018 |
| IPO Date | Mar 23, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | John Mastrototaro |
Contact Details
Address: 6800 Koll Center Parkway Pleasanton, California 94566 United States | |
| Phone | 415 651 3172 |
| Website | movano.com |
Stock Details
| Ticker Symbol | MOVE |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 1734750 |
| CUSIP Number | 62459M305 |
| ISIN Number | US62459M3051 |
| Employer ID | 82-4233771 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. John Mastrototaro Ph.D. | Chief Executive Officer, President and Director |
| Michael Aaron Leabman | Founder, Chief Technology Officer and Director |
| Jeremy Cogan C.F.A. | Chief Financial Officer and Secretary |
| Tyla Bucher | Chief Marketing Officer |
| Phil Kelly | Senior Vice President of Engineering |
| Michael Soule | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 22, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Dec 22, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 22, 2025 | S-4 | Filing |
| Dec 22, 2025 | 425 | Filing |
| Dec 22, 2025 | 8-K | Current Report |
| Dec 17, 2025 | 425 | Filing |
| Dec 17, 2025 | 8-K | Current Report |
| Nov 24, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | PRE 14A | Other preliminary proxy statements |